Patents matching “treatment”

US 10426817

Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimetics

MacRegen, Inc. · Granted Oct 1, 2019 · Expires Sep 26, 2039

US 10428057

Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

The Board of Regents of the University of Texas System · Granted Oct 1, 2019 · Expires Sep 26, 2039

US 10426771

6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

Sulfateq B.V. · Granted Oct 1, 2019 · Expires Sep 26, 2039

US 10420793

Composition of novel carbohydrate drug for treatment of human diseases

GALECTIN THERAPEUTICS, INC. · Granted Sep 24, 2019 · Expires Sep 19, 2039

US 10420747

Cancer treatment method using ailanthone compounds

EAST CHINA NORMAL UNIVERSITY · Granted Sep 24, 2019 · Expires Sep 19, 2039

US 10420748

Methods of treatment associated with the granulocyte colony-stimulating factor receptor

Ligand Pharmaceuticals Incorporated · Granted Sep 24, 2019 · Expires Sep 19, 2039

US 10416163

Method and treatment of recurring endometrial cancer with an inhibitor of USP14

Regents of the University of Minnesota · Granted Sep 17, 2019 · Expires Sep 12, 2039

US 10413616

Hydrogel prodrug for treatment

Viking Scientific, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

US 10413541

Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders

Lixte Biotechnology, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

US 10406241

Hydrogel prodrug for treatment

Viking Scientific, Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

US 10407488

Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation

The Regents of the University of California · Granted Sep 10, 2019 · Expires Sep 5, 2039

US 10406148

Methods of treatment using a JAK inhibitor compound

Theravance Biopharma R&D IP, LLC · Granted Sep 10, 2019 · Expires Sep 5, 2039

US 10399962

Azolopyrimidine for the treatment of cancer-related disorders

Arcus Biosciences, Inc. · Granted Sep 3, 2019 · Expires Aug 29, 2039

US 10398668

Glutamate treatment of cardiovascular disorders

The Board of Regents of the University of Oklahoma · Granted Sep 3, 2019 · Expires Aug 29, 2039

US 10398778

Method for enhancing specific immunotherapies in cancer treatment

Providence Health & Services—Oregon · Granted Sep 3, 2019 · Expires Aug 29, 2039

US 10391075

Antiviral treatments

BioCryst Pharmaceuticals, Inc. · Granted Aug 27, 2019 · Expires Aug 22, 2039

US 10383835

Treatment of inflammatory disorders in non-human mammals

The Regents of the University of California · Granted Aug 20, 2019 · Expires Aug 15, 2039

US 10383943

Compositions and related methods for the treatment of cancer

SOUTH DAKOTA BOARD OF REGENTS · Granted Aug 20, 2019 · Expires Aug 15, 2039

US 10378014

Compositions and methods for the treatment of influenza infection

Lakewood Amedex, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

US 10376510

2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer

Agios Pharmaceuticals, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

US 10376487

Method of treatment

VANDA PHARMACEUTICALS INC. · Granted Aug 13, 2019 · Expires Aug 8, 2039

US 10370366

Pyridazinone compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Aug 6, 2019 · Expires Aug 1, 2039

US 10369103

Neuroprotective liposome compositions and methods for treatment of stroke

The Board of Regents of the University of Texas System · Granted Aug 6, 2019 · Expires Aug 1, 2039

US 10364473

Fast diagnosis and personalized treatments for acne

The Regents of the University of California · Granted Jul 30, 2019 · Expires Jul 25, 2039